Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma

被引：0

作者：

Lucie Thorel

Pierre-Marie Morice

Hippolyte Paysant

Romane Florent

Guillaume Babin

Cécilia Thomine

Marion Perréard

Edwige Abeilard

Florence Giffard

Emilie Brotin

Christophe Denoyelle

Céline Villenet

Shéhérazade Sebda

Mélanie Briand

Florence Joly

Enora Dolivet

Didier Goux

Cécile Blanc-Fournier

Corinne Jeanne

Marie Villedieu

Matthieu Meryet-Figuiere

Martin Figeac

Laurent Poulain

Louis-Bastien Weiswald

机构：

[1] Université de Caen Normandie,

[2] INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment),undefined

[3] BioTICLA Laboratory (Precision Medicine for Ovarian Cancers),undefined

[4] Université de Caen Normandie,undefined

[5] Services Unit PLATON,undefined

[6] ORGAPRED Core Facility,undefined

[7] UNICANCER,undefined

[8] Comprehensive Cancer Center François Baclesse,undefined

[9] UNICANCER,undefined

[10] Comprehensive Cancer Center Francois Baclesse,undefined

[11] Department of Surgery,undefined

[12] Université de Caen Normandie,undefined

[13] Services Unit PLATON,undefined

[14] ImpedanCell Core Facility,undefined

[15] University of Lille,undefined

[16] CNRS,undefined

[17] Inserm,undefined

[18] CHU Lille,undefined

[19] Institut Pasteur de Lille,undefined

[20] UNICANCER,undefined

[21] Comprehensive Cancer Center Francois Baclesse,undefined

[22] Biological Resources Center ‘OvaRessources’,undefined

[23] UNICANCER,undefined

[24] Comprehensive Cancer Center Francois Baclesse,undefined

[25] Clinical Research Department,undefined

[26] Université de Caen Normandie,undefined

[27] Services Unit EMERODE,undefined

[28] « Centre de Microscopie Appliquée À La Biologie » CMAbio3,undefined

[29] UNICANCER,undefined

[30] Comprehensive Cancer Center Francois Baclesse,undefined

[31] Department of Biopathology,undefined

来源：

Journal of Experimental & Clinical Cancer Research | / 42卷

关键词：

Ovarian clear cell carcinoma; Patient-derived tumor organoids; Patient-derived xenograft; Patient-derived cell lines; Precision medicine; Predictive functional assays;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 236 条

[1]

Daniel VC(2009)A primary xenograft model of small cell lung cancer reveals irreversible changes in gene expression imposed by culture in-vitro Cancer Res 69 3364-15

[2]

Marchionni L(2015)Spherical cancer models in tumor biology Neoplasia 17 1-2605

[3]

Hierman JS(2017)Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors Ann Oncol 28 2595-73

[4]

Rhodes JT(2014)Organoid cultures for the analysis of cancer phenotypes Curr Opin Genet Dev 24 68-371

[5]

Devereux WL(2018)Personalized cancer medicine: an organoid approach Trends Biotechnol 36 358-35

[6]

Rudin CM(2021)Patient-derived organoids as a predictive biomarker for treatment response in cancer patients NPJ Precis Oncol 5 30-1100

[7]

Weiswald L-B(2022)Functional precision oncology: testing tumors with drugs to identify vulnerabilities and novel combinations Cancer Cell 40 26-304

[8]

Bellet D(2017)Tumor organoids as a pre-clinical cancer model for drug discovery Cell Chem Biol 24 1092-2589

[9]

Dangles-Marie V(2019)Epithelial ovarian cancer: evolution of management in the era of precision medicine CA Cancer J Clin 69 280-4754

[10]

Izumchenko E(2000)Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2584-542

← 1 2 3 4 5 6 7 8 9 10 →